Related Experiment Video
Updated: Aug 10, 2026

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
Mathematical modelling of chemotherapy in HIV infection
1Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Praha.
Abstract:
A mathematical model of CD4+ lymphocyte depletion in HIV infection is used to simulate and analyse the effect of AZT treatment. In most cases, permanent administration of AZT is observed to stop the CD4+ lymphocyte count decline and to stimulate their increase up to a new steady-state level, which depends on the intensity of AZT treatment, i.e. AZT dose. Temporary administration of AZT leads only to a temporary increase in CD4+ lymphocyte count. After the treatment is terminated, the count starts to decline again. However, the resulting prolongation of patient's survival exceeds the time interval of AZT administration. Interestingly, the survival prolongation is greater, if the treatment is started at five than at two years after the infection and there is no striking increase in survival time if a dose of AZT inhibiting 75% of HIV proliferation is used instead of a lower one inducing 25% inhibition only.
Related Concept Videos
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs
On the other hand, integral calculus focuses on...
Fundamental Mathematical Principles in Pharmacokinetics: Mathematical Expressions and Units
One significant application of mathematics in pharmacokinetics is the characterization of drug distribution through the volume of distribution...
Two-Compartment Open Model: IV Infusion
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
Three-Compartment Open Model
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

